Burning Rock Biotech Limited American Depositary Shares (BNR)
Stock · NASDAQ · Health Care
$10.19as of 8/28/2026
Price chart
Open in TradingViewActive signals
High Beta28.1%
Support level
$8.91
Industry
Medical Specialities
About BNR
Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS)-based tissue, liquid biopsy cancer therapy selection, and prognosis prediction tests for various cancer…
- Sector
- Health Care
- Industry
- Medical Specialities
- Employees
- 667
- Website
- www.brbiotech.com/
Fundamentals
- 1-day range
- $9.79$10.2
- Market cap
- $93.65M
- P/E (trailing)
- —
- P/E (forward)
- -17.57
- EPS (trailing)
- $-0.56
- Dividend yield
- —
- Beta
- 1.51
- Avg. volume
- 16.8K
52-week range
$6.79$41.72
Burning Rock Biotech Limited American Depositary Shares Competitors
Chosen by industry and closest market cap.
- BNRBurning Rock Biotech Limited American Depositary Shares$10.19▲ 1.90%Market cap $93.65MP/E —$6.79$41.72
- KEQUKewaunee Scientific Corporation Common Stock$37.78▼ 0.50%Market cap $108.73MP/E 10.89$33.27$59
- SERASera Prognostics Inc. Class A Common Stock$2.07▲ 0.49%Market cap $78.32MP/E —$1.56$3.95
- XGNExagen Inc. Common Stock$7.38▼ 1.86%Market cap $159.64MP/E —
- ACHAccendra Health Inc. Common Stock$1.22▲ 0.83%Market cap $223.62MP/E —$0.9337$5.69
- TLSITriSalus Life Sciences Inc. Common Stock$4.85▼ 1.62%Market cap $299.10MP/E —$2.2$7.95
- CSTLCastle Biosciences Inc. Common Stock$33.57▼ 2.03%Market cap $930.84MP/E —$17.72$44.28
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| BNR Burning Rock Biotech Limited American Depositary Shares | $93.65M | — | $10.19 | ▲ 1.90% | $6.79$41.72 |
| KEQU Kewaunee Scientific Corporation Common Stock | $108.73M | 10.89 | $37.78 | ▼ 0.50% | $33.27$59 |
| SERA Sera Prognostics Inc. Class A Common Stock | $78.32M | — | $2.07 | ▲ 0.49% | $1.56$3.95 |
| XGN Exagen Inc. Common Stock | $159.64M | — | $7.38 | ▼ 1.86% | |
| ACH Accendra Health Inc. Common Stock | $223.62M | — | $1.22 | ▲ 0.83% | $0.9337$5.69 |
| TLSI TriSalus Life Sciences Inc. Common Stock | $299.10M | — | $4.85 | ▼ 1.62% | $2.2$7.95 |
| CSTL Castle Biosciences Inc. Common Stock | $930.84M | — | $33.57 | ▼ 2.03% | $17.72$44.28 |
P/E shows — for peers not currently carrying a live signal of their own.
Insider Activity
Insider Actions →Acquired
1.05M
Disposed
0
- Yusheng Han · June 26, 2026 · Buy24.9K @ $8
- Yusheng Han · June 24, 2026 · Buy250.0K @ $8
- Yusheng Han · June 23, 2026 · Buy6.0K @ $7.5
- Yusheng Han · June 22, 2026 · Buy104.7K @ $7.45
- Yusheng Han · June 16, 2026 · Buy111.1K @ $9
- Yusheng Han · June 12, 2026 · Buy210.0K @ $9.25
- Yusheng Han · June 11, 2026 · Buy24.8K @ $8.74
- Yusheng Han · March 31, 2026 · Buy314.9K @ $17.36
Institutional Ownership
March 31, 2026
- Total shares held
- 1.71M
- Total value held
- $27.35M
- Institutional holders
- 15
Top holders this quarter
- Unknown1.23M
- Unknown282.1K
- Unknown35.4K
- Unknown30.1K
- Unknown30.1K
- Unknown29.2K
- Unknown21.2K
- Unknown18.3K
- Unknown17.7K
- Unknown15.3K
See the full, filterable feed with live charts on the MarketWall dashboard.